Stock MPSYF MORPHOSYS AG
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases MorphoSys AG OTC Markets

Equities

MPSYF

DE0006632003

Market Closed - OTC Markets
Other stock markets
 03:33:07 2024-07-09 pm EDT 		5-day change 1st Jan Change
73.27 USD +2.10% Intraday chart for MorphoSys AG 0.00% +78.71%
Jul. 17 Oxford Biomedica Names New Finance Chief MT
Jul. 17 K3 Business sees interim revenue decline AN

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MorphoSys AG - Ad hoc, Merger Squeeze-out Cash Compensation Determined at EUR 68.00
AQ
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
AQ
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
BU
MorphoSys Announces Voluntary Delisting from the Nasdaq Global Market
EQ
Ad hoc: Merger Squeeze-out Cash Compensation Determined at EUR 68.00
EQ
AFR: MorphoSys AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
MorphoSys AG: Correction of a release from 18/04/2024 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
InnoCare Announces the Acceptance of Biologics License Application for Tafasitamab in Combination with Lenalidomide for the treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Adult Patients
AQ
MOR STOCK ALERT: Halper Sadeh LLC Is Investigating Whether the Sale of MorphoSys AG Is Fair to Shareholders
BU
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
BU
MorphoSys and Novartis Sign Delisting Agreement and Intend to Implement a Merger Squeeze-out of MorphoSys’ Minority Shareholders
EQ
Ad hoc: Novartis BidCo Germany AG Intends to Implement a Merger Squeeze-out of MorphoSys AG’s Minority Shareholders
EQ
Deutsche Borse-Unscheduled component changes in MDAX and TecDAX
AQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
Ad hoc, Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO
AQ
Ad hoc: Arkadius Pichota and Lukas Gilgen appointed to Management Board of MorphoSys AG replacing the current CEO and CFO
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
MorphoSys AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MOR Stock
  4. MPSYF Stock
  5. News MorphoSys AG
  6. Press Releases